Enanta Pharmaceuticals
ENTA
#8008
Rank
โ‚ฌ0.18 B
Marketcap
8,88ย โ‚ฌ
Share price
2.53%
Change (1 day)
8.68%
Change (1 year)

Revenue for Enanta Pharmaceuticals (ENTA)

Revenue in 2024 (TTM): โ‚ฌ66.72 Million

According to Enanta Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ68.6 Million. In 2023 the company made a revenue of โ‚ฌ66.59 Million a decrease over the revenue in the year 2022 that were of โ‚ฌ76.53 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Enanta Pharmaceuticals from 2012 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚ฌ66.72 M0.19%
2023 โ‚ฌ66.59 M-12.98%
2022 โ‚ฌ76.53 M-6.78%
2021 โ‚ฌ82.1 M-0.65%
2020 โ‚ฌ82.63 M-50.73%
2019 โ‚ฌ0.16 B-19.52%
2018 โ‚ฌ0.20 B91.59%
2017 โ‚ฌ0.10 B127.72%
2016 โ‚ฌ47.76 M-60.38%
2015 โ‚ฌ0.12 B17.92%
2014 โ‚ฌ0.10 B2675.61%
2013 โ‚ฌ3.68 M-92.92%
2012 โ‚ฌ52.03 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ52.43 B 76,331.35%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ83.60 B 121,767.70%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ9.85 B 14,265.48%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ59.56 B 86,724.62%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ45.22 B 65,818.57%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ47.61 B 69,299.67%๐Ÿ‡จ๐Ÿ‡ญ Switzerland